Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
2025 · 1st Quarter (Jan 1 - Mar 31)
ORGANOGENESIS INC.
Filed by ARENTFOX SCHIFF LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 19, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- ARENTFOX SCHIFF LLP
- Client
- ORGANOGENESIS INC.
- Filing UUID
- 4b6fa0ca-9dcd-4b87-91cc-b350430519b5
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Food and Drug Administration policy on chronic wound healing products
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.